Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Perinatal Guidelines Update

November 17, 2005

The "Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States" have been revised to include:

Updates to Clinical Scenario #3. The new information discusses a 3- to 7-day "tail" of postpartum maternal ZDV/3TC following single dose maternal/infant nevirapine; this "tail" may reduce the risk of nevirapine resistance.

  • Updated information on the role of cesarean delivery in preventing mother-to-child transmission of HIV.

  • An updated Supplement: "Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy," including a new section on tipranavir.

    Advertisement

  • A Perinatal Antiretroviral Guidelines Working Group Conflict of Interest Disclosure (Appendix).

Updated information appears highlighted in yellow.

You can download the updated guidelines, or request to receive them by e-mail or hard copy from the AIDSinfo Web site.

The AIDSinfo Web site is also a useful source of other information related to HIV/AIDS, including other treatment and prevention guidelines, downloadable databases for PDAs (Personal Digital Assistants), fact sheets and HIV/AIDS-related clinical trials information.




  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by U.S. Food and Drug Administration. Visit the FDA's website to find out more about their activities and publications.
 

Tools
 

Advertisement